Skip to content
Open access

Trend Analysis of Hepatitis C Seroreactivity in Voluntary Blood Donors at a Stand-Alone Blood Centre: A Retrospective Study

Oct 2026 · International Journal of Drug Delivery Technology · Vol 16 · 0 citations · 10 references

TL;DR

It is demonstrated that HCV seroreactivity among voluntary blood donors remained consistently low over the six-year study period, reflecting the effectiveness of existing blood safety measures and the need to monitor local donor demographics.

Abstract

Background: Hepatitis C virus (HCV) is a major transfusion-transmitted infection and remains an important public health concern. Blood donor screening is essential for ensuring blood safety. This study aimed to determine the seroprevalence of HCV and analyse its temporal trend among voluntary blood donors at a standalone blood centre in Ahmedabad district, Gujarat, over a six-year period. Methods: A retrospective record-based study was conducted at stand-alone blood centre in Ahmedabad District, Gujarat, India, over a six-year period from January 2020 to December 2025. Data from all voluntary blood donors who successfully donated blood during the study period were included. Donor blood samples were initially screened for anti-HCV antibodies using a third-generation Enzyme-Linked Immunosorbent Assay (ELISA). Initially reactive samples were retested and confirmed using Chemiluminescent Microparticle Immunoassay (CMIA). The collected data were analysed to calculate annual and overall HCV prevalence and to observe changes across the study years. Results: A total of 332,639 blood donations were analysed. Overall, 230 donations were confirmed HCV reactive, giving a prevalence of 0.069%. Annual prevalence ranged from 0.039% to 0.111%. The highest prevalence was observed in 2025. While the overall prevalence remained low, an increase in HCV-reactive donations was observed during 2024 and 2025. Conclusion: The findings demonstrate that HCV seroreactivity among voluntary blood donors remained consistently low over the six-year study period, reflecting the effectiveness of existing blood safety measures. The late increase in seroprevalence highlights the need to monitor local donor demographics and evaluate whether supplementary testing methods like nucleic acid testing (NAT) should be integrated to reduce window-period risks.

Read PDF

Similar papers

Open access Oct 2026

Seropositivity and trends of transfusion transmitted infections among blood donors at blood center of tertiary care hospital of Marathwada region, Maharashtra, India

Background: Blood transfusion is a life-saving intervention that has an essential role in patient management within health care system. The establishment of systems to ensure that all donated blood screened for transfusion -transmissible infections is a core component of every national blood programme. Testing for TTI’...

Ashwini R. Tangde, Vijaya Wane, B. Sonwane · 0 citations
Open access Oct 2026

Hepatitis B Surface Antigen and Hepatitis C Antibody Seroprevalence Among Male Blood Donors in Lahore, Pakistan: A Cross-Sectional Study at Four Blood Banks

Seroprevalence among male blood donors in Lahore, Pakistan represents screening-marker seroprevalence rather than confirmed active infection and should be interpreted within the limitations of rapid testing and the sampled male donor population.

Muskan Naseer, F. Ali, M. Butt et al. · 0 citations
Open access Oct 2026

Seroprevalence and trends of transfusion-transmissible infections among blood donors in the Volta Region, Ghana: A four-year retrospective study

Background Blood transfusion is a life-saving intervention; however, transfusion-transmissible infections (TTIs) such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis remain major public health concerns, particularly in low- and middle-income countries. This study as...

S. Ayanku, E. K. Hanu, L. Akuba et al. · 0 citations
Open access Oct 2026

Association of Transfusion-Transmitted Infections with ABO and Rh Blood Group System in Healthy Blood Donors in Marrakech, Morocco

Background: TTIs remain a major threat to transfusion safety. This study assessed the association between ABO/Rh blood groups and HBV, HIV, HCV, and syphilis among 4.038 apparently healthy blood donors. Methods: A retrospective cross-sectional study was conducted at the Moroccan Blood Agency and its Derivatives in Marr...

Abdelaziz Ait Melloul, Morad Kaddouri, M. Ouhammou et al. · 0 citations
Open access Nov 2026

Prevalence of Reactive Screening Markers for HIV, Hepatitis B, Hepatitis C, and Syphilis Among Blood Donors at the Provincial Hospital of Sarh, Chad: A Retrospective Cross-Sectional Study

HBV and syphilis were the most frequent reactive screening markers among blood donors at Sarh Provincial Hospital, Chad, and strengthening voluntary non-remunerated donation, quality assurance, confirmatory testing, and surveillance may improve blood safety.

A. Mahamat, Mahamat Hassan Abdel-aziz, Abdoulaye Brahim Bechir et al. · 0 citations
Open access Oct 2026

Comparative Evaluation of Rapid Diagnostic Test and Elisa Technique in Screening Donors for HIV and Syphilis in Some Blood Banks in Bayelsa State, Nigeria

Blood transfusion is an important component of health care; hence, the screening of blood donors for transfusion-transmissible infections. This study compared rapid diagnostic methods with ELISA assay in the screening of blood donors for Human Immunodeficiency Virus and syphilis in some selected blood banks in Bayel...

Christian Atiegha · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.